Companies: 10,795·Total market cap: $144.5T
CellaVision AB (publ)

CellaVision AB (publ)

CLVSFOTCHealthcare● Active
$13.49
+$0.00(+0.00%)
Market Cap$321757369
P/E Ratio
52W High$19.2796
52W Low$13.49

CellaVision AB (publ)(CLVSF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CLVSF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.76B$0.72B$0.68B$0.64B$0.57B
Cost of Revenue$0.24B$0.24B$0.21B$0.20B$0.17B
Gross Profit$0.52B$0.49B$0.46B$0.44B$0.39B
Gross Margin %(computed)68.50%67.35%68.37%68.56%69.37%
Operating Expenses
R&D Expenses$0.10B$0.09B$0.08B$0.09B$0.06B
G&A Expenses$0.09B$0.09B$0.08B$0.07B$0.06B
Total Operating Expenses$0.32B$0.31B$0.30B$0.28B$0.23B
Operating Income$0.20B$0.18B$0.17B$0.16B$0.16B
Operating Margin %(computed)26.62%24.57%24.66%24.75%28.77%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.19B$0.18B$0.16B$0.15B$0.16B
Income Tax Expense$0.04B$0.04B$0.03B$0.03B$0.03B
Net Income$0.15B$0.14B$0.13B$0.12B$0.13B
Net Margin %(computed)20.17%19.46%19.24%18.51%22.16%
Per Share & EBITDA
EPS (Basic)$6.42$5.90$5.46$4.96$5.25
Wtd Avg Shares0.02B0.02B0.02B0.02B0.02B
EBITDA$0.24B$0.22B$0.21B$0.19B$0.19B
EBITDA Margin %(computed)31.19%30.39%30.60%29.85%34.23%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · SEK · B

深入了解CellaVision AB (publ)

关于CellaVision AB (publ)(CLVSF)损益表

CellaVision AB (publ)(CLVSF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CLVSF实现营收$0.76B,毛利润$0.52B(毛利率68.50%),净利润$0.15B(净利率20.17%)。

常见问题

CLVSF · 4 问

CellaVision AB (publ)(CLVSF)2025财年营收为$0.76B,同比up4.9%。

CLVSF revenueCLVSF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09